Radioisotope firm Nordion is expected to benefit from $9.7 million in funding from the U.S. Department of Energy (DOE) to develop a way to use low-enriched uranium (LEU) to manufacture medical isotopes.
The DOE's National Nuclear Security Administration (NNSA) awarded the money to General Atomics to advance its work with Nordion and the University of Missouri Research Reactor (MURR) Center. Nordion has been working with General Atomics and MURR since February to develop a new source of medical isotopes using General Atomics' selective gaseous extraction (SGE) technology.
With all program planning now complete and the project well underway, Nordion and its partners expect to begin supplying isotopes by the end of this year.
